Retail value growth for medicated skin care in Greece slowed down to 3% in 2009. This can be largely attributed to the effects of the current economic crisis. Consumers became increasingly budget-conscious and attempted to cut expenditure wherever possible. For many, purchases of some medicated skin care products began to be regarded as unnecessary and as a result, the growth recorded for the category was slow.

 

Euromonitor International' s Medicated Skin Care in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

 

Product coverage: Acne Treatments, Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Medicated Skin Care, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals

 

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

 

Why buy this report?

* Get a detailed picture of the Consumer Health industry;

* Pinpoint growth sectors and identify factors driving change;

* Understand the competitive environment, the market’s major players and leading brands;

* Use five-year forecasts to assess how the market is predicted to develop.

 

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.